Is Celcuity (CELC) Stock a Buy?
While early-stage biopharmaceutical firms typically lack historic multi-year revenue growth (0% 3-year CAGR at $0.00 TTM revenue), positive operating cash flow generation (-$153.3M TTM), or positive free...
Celcuity Inc. (CELC)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,000,000 | $3,618,627 | 1.62% | ||
| 2. | 2,500,000 | $2,414,825 | 1.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.02 | 4,212 | $244,395.40 | 7,211,484 | 2025-09-08 | Filing | |
| $58.02 | 388 | $22,513.16 | 704,308 | 2025-09-08 | Filing | |
| $56.22 | 151,524 | $8,518,679.28 | 7,207,272 | 2025-09-08 | Filing | |
| $56.22 | 13,976 | $785,730.72 | 703,920 | 2025-09-08 | Filing | |
| $10.32 | 10,000 | $103,187.00 | 10,250 | 2023-05-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $102.50 | 2,838,632 | $290,959,780.00 | 4,372,852 | 2026-07-14 | Filing | |
| $102.50 | 261,368 | $26,790,220.00 | 442,940 | 2026-07-14 | Filing | |
| $140.68 | 25,000 | $3,517,000.00 | 65,000 | 2026-05-04 | Filing | |
| $143.24 | 365 | $52,281.80 | 6,760 | 2026-05-04 | Filing | |
| $142.04 | 2,825 | $401,251.14 | 7,125 | 2026-05-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 93,210 | $7,412,059 | 0.22% | |
| 2. | 15,792 | $1,071,803 | 0% | |
| 3. | 431,000 | $415,432 | 0.04% | |
| 4. | 1,515 | $120,473 | 0.01% | |
| 5. | 1,068 | $84,927 | 0% |
News See All
Celcuity (CELC): Landmark Approval Collides With A Costly Launch
On August 13, Celcuity (NASDAQ:CELC) walked investors through a quarter unlike any in the company's history.
12 Best High Short Interest Stocks With Highest Upside Potential
In this article, we will discuss the 12 Best High Short Interest Stocks With Highest Upside Potential.
Celcuity Inc. (NASDAQ:CELC) Q1 2026 Earnings Call Transcript
Celcuity Inc. (NASDAQ:CELC) Q1 2026 Earnings Call Transcript May 14, 2026Celcuity Inc. beats earnings expectations. Reported EPS is $-0.97, expectations were $-1.07.
Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential
In this article, we discuss the Billionaire Joe Edelman's Stock Picks with Huge Upside Potential.
Celcuity Inc. (NASDAQ:CELC) Q4 2025 Earnings Call Transcript
Celcuity Inc. (NASDAQ:CELC) Q4 2025 Earnings Call Transcript March 25, 2026Celcuity Inc. beats earnings expectations. Reported EPS is $-0.97, expectations were $-1.06.
Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances
Apis Capital Advisors’ Apis Flagship Fund released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC)
Celcuity Inc. (NASDAQ:CELC) is among the 20 Best Performing Stocks in 2025. On December 12, 2025, TheFly reported that Wells Fargo started covering Celcuity Inc.
20 Best Performing Stocks in 2025
In this article, we will discuss: 20 Best Performing Stocks in 2025. Reuters reported on January 1, 2026, that U.S.
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results
We recently published 10 Market Stars Behind Millionaire-Making in 2025. Celcuity Inc. (NASDAQ:CELC) is one of the top performers.
Hedge Fund Resource Center